DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
NCT07290608
Artificial Intelligence, Cardiovascular Diseases
São Paulo, Brazil
View Trial DetailsNCT Number: NCT02108041
Background:
-How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice.
Objective:
-To study how physicians make personalized treatment decisions
Eligibility:
-Healthy adult primary care physicians who are internal (or family) medicine residents.
Design:
* Participants will complete a screening form. * Participants will put on a headset, called a head-mounted display, showing a virtual reality environment. * The environment will contain an exam room and the virtual patient. * After interacting with the virtual patient, participants will complete a series of survey measures. * Participation will last for about 60 minutes. The virtual patient interaction and follow-up questions will be audio taped.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
This study will examine factors related to primary care physicians clinical decision-making. Using a virtual clinical interaction experiment, we aim to better understand physicians decision-making processes and to explore their communication behaviors toward patients in the clinical encounter. Physician participants will enter a virtual exam room where they will be asked to respond to a virtual patient, acting as her primary care physician in a follow-up visit to evaluate her for depression. Various aspects of physician communication in the virtual clinic and self-report measures related to decision-making will be analyzed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
NHGRI employees are excluded for this protocol because they are likely to have specialized genomic knowledge and may think differently about genomics in the clinical interaction.
Time frame: Outcome measurements are assessed on the same date of the study visit.
To explore how physicians use genetic testing for anticoagulant (warfarin) dosage in patients of different racial /ethnic and SES backgrounds
National Human Genome Research Institute (NHGRI)
Nih
Medical Decision-Making in a Virtual Clinical Setting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07290608
Artificial Intelligence, Cardiovascular Diseases
São Paulo, Brazil
View Trial DetailsNCT00839163
Cardiovascular Diseases, Deep Vein Thrombosis
Sydney, New South Wales, Australia
View Trial DetailsNCT04373707
COVID, Cardiovascular Diseases
Amiens, France
View Trial DetailsNCT02555111
Cardiovascular Diseases, Chronic Portal Vein Thrombosis
Clichy, France
View Trial Details